German Christopher Paul bought RYTM
May 15, 2026 · Form 4 insider transaction
German Christopher Paul bought 1,406 shares of Rhythm Pharmaceuticals, Inc. at $17.97 per share, a transaction worth $25.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,406
Price
$17.97
Total value
$25.3K
InsiderGerman Christopher Paul
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 15, 2026
Filing dateMay 19, 2026
Shares owned after4,643
OwnershipDirect
10b5-1 planNo
AmendedNo